In the present study we focused on the expression of c-Fos, Fra-1, Fra-2, Fos-B, c-Jun, Jun-B and Jun-D in human breast cancer tumors and adjacent non-tumor tissues with the aim to assay the potential of these molecules as novel biomarkers. The gene discussed is FOSL1; the disease is breast carcinoma.